Clinical Research Directory
Browse clinical research sites, groups, and studies.
Percutaneous Gelled Alcohol Sclerotherapy for Aggressive Angiomas: Evaluation of Feasibility, Safety, and Efficacy
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Summary
The investigators aimed to evaluate efficacy and safety of a non-surgical protocol treatment combining transarterial embolization and percutaneous radiopaque gelled ethanol (RGE) sclerotherapy in a first procedure, then followed by vertebroplasty in a second procedure, to treat aggressive vertebral hemangioma patients in tertiary hospital. Exclusion criteria were age \<18-years old and any association with neurological deficit.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
11
Start Date
2024-06-25
Completion Date
2024-12
Last Updated
2024-10-08
Healthy Volunteers
No
Conditions
Interventions
Collecting data from medical records
Data collected: clinical data (particularly pain), biological data, imaging.
Locations (1)
CHU de Saint-Etienne
Saint-Priest-en-Jarez, France